Quest Products LLC Launches a Nasal Filter Device that Blocks Microscopic Airborne Particles and Pollutants

Quest Products, LLC introduces a new nasal filter designed for people interested in protection against the smallest of airborne particles and pollutants.

Its unique filtration material is electrostatically charged to better capture microscopic particles and protect people from droplets released during coughing and sneezing. In a study by LMS Technologies, the new breatheWELL Nasal Filter was proven as a unique barrier against airborne particles measuring as small as 3 microns. In fact, the study demonstrated a 90 percent effectiveness against particles measuring 10 microns and 60 percent effectiveness against particles measuring 2.5 microns—this is within the micron measurement range of the smallest sized bacteria, pollen and allergen. According to the results of the study, the nasal filters can block up to 99% of airborne particles and pollutants.

“In recent news reports, immunology and allergy specialists encourage people to do all they can to alleviate inflammation to the lungs caused by breathing in common allergens because it may leave them more susceptible to respiratory illnesses,” said Jon Romanow, Director of Marketing, Quest Products, LLC. “We believe that our new product will be helpful to people seeking additional options to protect their overall health by blocking the inhalation of pollens, pollutants and bacteria that reach the lungs through the nose. These filters are ideal for protection during travel when around pets or while working in dusty environments.”

The unique filtration material makes breatheWELL™ a reliable option for reducing direct and indirect airborne transmission of unwanted particles breatheWELL™ nasal filters fit discreetly into the front of the nostrils. It is drug-free, latex-free and the rings are made of a surgical-grade polymer that is non-toxic.

breatheWELL™ is available now for purchase online at Amazon and at breatheandsleepwell.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version